{"entity":{"id":"eritrea-nmfa","kind":"institution","name":"National Medicines and Food Administration, Eritrea (NMFA)","aka":["NMFA","National Medicines and Food Administration","National Food and Medicine Administration"],"tldr":"The unit of Eritrea's Ministry of Health that regulates medicines and medical devices. It receives registration dossiers for medical devices and has recalled substandard or falsified products found through the Eritrean Pharmacovigilance Centre's monitoring.","summary":"WHO's Regional Office for Africa, reporting a June 2019 workshop on a medical devices registration guideline, describes the National Medicines and Food Administration as the unit to which applicants submit product dossiers before any procurement. A 2021 paper in Drug Safety by the administration's own staff, who give it as part of the Ministry of Health, says that monitoring through the Eritrean Pharmacovigilance Centre found about 55 medical products that were substandard or falsified, which the administration recalled from the Eritrean market, and that the centre had reached maturity level three on a WHO rapid benchmarking assessment; that statement is the authors' and concerns the monitoring of medicine safety, not the regulator as a whole. WHO's August 2026 list of regulators operating at maturity level 3 or 4 does not include Eritrea. WHO's Country Planning Cycle Database lists Proclamation No 36/1993, to control drugs, medical supplies and sanitary items, among Eritrea's health laws; OnCo has not read its text. OnCo found no website for the administration and no published rules on how cancer medicines are registered or clinical trials authorised. The coordinates are an approximate city point for Asmara.","asOf":"2026-11-16","links":[{"label":"WHO Regional Office for Africa: consensus building workshop on the medical devices registration guideline (31 July 2019)","url":"https://www.afro.who.int/countries/eritrea/news/eritrea-consensus-building-workshop-medical-devices-registration-guideline"},{"label":"Russom et al., the Eritrean pharmacovigilance system (Drug Saf 2021)","url":"https://doi.org/10.1007/s40264-021-01102-x"},{"label":"WHO Country Planning Cycle Database: Eritrea, main legislative instruments","url":"https://extranet.who.int/cpcd/health-legislation/countries/eri/legislative-instruments"},{"label":"WHO: regulators operating at maturity level 3 and 4 (August 2026, PDF)","url":"https://cdn.who.int/media/docs/default-source/medicines/regulatory-systems/wla/list-of-nras-operating-at-ml3-and-ml4.pdf"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["eritrea-ministry-of-health","who"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Asmara","country":"ER","lat":15.339,"lng":38.933,"institutionType":"government","programs":["Registration of medical devices","Recall of substandard or falsified medical products"]},"route":"/institutions/eritrea-nmfa/","neighbours":{"institution":[{"id":"eritrea-ministry-of-health","kind":"institution","name":"Ministry of Health, Eritrea","route":"/institutions/eritrea-ministry-of-health/"},{"id":"who","kind":"institution","name":"World Health Organization Cancer Programme","route":"/institutions/who/"}],"paper":[{"id":"paper-abraha-leukaemia-eritrea-cancer-reports-2025","kind":"paper","name":"Leukaemia in Eritrea, 2010 to 2020: laboratory records from Asmara","route":"/key-papers/paper-abraha-leukaemia-eritrea-cancer-reports-2025/"}]}}